{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T04:41:46Z","timestamp":1786250506617,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Project of Capacity Enhancement of Institutional Clinical Trials in Suzhou","award":["SLT2023030"],"award-info":[{"award-number":["SLT2023030"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172076"],"award-info":[{"award-number":["82172076"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Construction Project of High-End Clinical Medical Technology Platform and Translational Base of Soochow University and China Postdoctoral Science Foundation","award":["2024M750521"],"award-info":[{"award-number":["2024M750521"]}]},{"name":"Key Scientific Program of Jiangsu Provincial Health Commission","award":["ZD2021033"],"award-info":[{"award-number":["ZD2021033"]}]},{"name":"The Project of Clinical Innovation and Interdisciplinary Translation of Soochow University","award":["ML12301623"],"award-info":[{"award-number":["ML12301623"]}]},{"name":"Project of Medical New Technology Assistance of the Second Affiliated Hospital of Soochow University","award":["23ZL004"],"award-info":[{"award-number":["23ZL004"]}]},{"name":"Project of Medical New Technology Assistance of the Second Affiliated Hospital of Soochow University","award":["23ZL012"],"award-info":[{"award-number":["23ZL012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1245\/s10434-026-19610-4","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T23:16:10Z","timestamp":1777245370000},"page":"8071-8083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does Lymph Node Dissection During Esophagectomy Impact the Long-Term Prognosis for Complete Responders After Neoadjuvant Therapy? A Meta-analysis"],"prefix":"10.1245","volume":"33","author":[{"given":"Xianbo","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peidong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"3","key":"19610_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin."},{"issue":"12","key":"19610_CR2","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/j.jtho.2016.07.031","volume":"11","author":"P Samson","year":"2016","unstructured":"Samson P, Robinson C, Bradley J, et al. Neoadjuvant chemotherapy versus chemoradiation prior to esophagectomy: impact on rate of complete pathologic response and survival in esophageal cancer patients. J Thorac Oncol. 2016;11(12):2227\u201337.","journal-title":"J Thorac Oncol."},{"key":"19610_CR3","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.annonc.2022.07.003","volume":"33","author":"R Obermannov\u00e1","year":"2022","unstructured":"Obermannov\u00e1 R, Alsina M, Cervantes A, et al. Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33:992\u20131004.","journal-title":"Ann Oncol."},{"key":"19610_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/annonc\/mdy498","volume":"30","author":"K Muro","year":"2019","unstructured":"Muro K, Lordick F, Tsushima T, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS SSO and TOS. Ann Oncol. 2019;30:34\u201343.","journal-title":"Ann Oncol."},{"key":"19610_CR5","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1200\/JCO.22.02279","volume":"41","author":"M Faron","year":"2023","unstructured":"Faron M, Cheugoua-Zanetsie M, Tierney J, et al. Individual participant data network meta-analysis of neoadjuvant chemotherapy or chemoradiotherapy in esophageal or gastroesophageal junction carcinoma. J Clin Oncol. 2023;41:4535\u201347.","journal-title":"J Clin Oncol."},{"issue":"24","key":"19610_CR6","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.21037\/atm-22-6186","volume":"10","author":"Z Sun","year":"2022","unstructured":"Sun Z, Zheng J, Xu X, Zhao X, Ma X, Ye Q. Comparison of clinical outcomes of conservative treatment and surgery for esophageal cancer patients who achieve a clinical complete response following neoadjuvant chemoradiotherapy: a systematic review and meta-analysis. Ann Transl Med. 2022;10(24):1378.","journal-title":"Ann Transl Med."},{"issue":"1","key":"19610_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/ejcts\/ezx261","volume":"53","author":"YK Chao","year":"2018","unstructured":"Chao YK, Chuang WY, Yeh CJ, Chang HK, Tseng CK. Anatomical distribution of residual cancer in patients with oesophageal squamous cell carcinoma who achieved clinically complete response after neoadjuvant chemoradiotherapy. Eur J Cardiothorac Surg. 2018;53(1):201\u20138.","journal-title":"Eur J Cardiothorac Surg."},{"key":"19610_CR8","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.jtcvs.2020.09.042","volume":"162","author":"H Tang","year":"2021","unstructured":"Tang H, Jiang D, Zhang S, et al. Residual tumor characteristics of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg. 2021;162:1632\u201341.","journal-title":"J Thorac Cardiovasc Surg."},{"key":"19610_CR9","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/SLA.0000000000005636","volume":"276","author":"IYH Wong","year":"2022","unstructured":"Wong IYH, Chung JCY, Zhang RQ, et al. A Novel tumor staging system incorporating tumor regression grade (TRG) with lymph node status (ypN-Category) Results in better prognostication than ypTNM stage groups after neoadjuvant therapy for esophageal squamous cell carcinoma. Ann Surg. 2022;276:784\u201391.","journal-title":"Ann Surg."},{"key":"19610_CR10","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/SLA.0000000000004238","volume":"275","author":"T Hagi","year":"2022","unstructured":"Hagi T, Makino T, Yamasaki M, et al. Pathological regression of lymph nodes better predicts long-term survival in esophageal cancer patients undergoing neoadjuvant chemotherapy followed by surgery. Ann Surg. 2022;275:1121\u20139.","journal-title":"Ann Surg."},{"key":"19610_CR11","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/his.13491","volume":"72","author":"N Davarzani","year":"2018","unstructured":"Davarzani N, Hutchins GGA, West NP, et al. Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trial. Histopathology. 2018;72:1180\u20138.","journal-title":"Histopathology."},{"key":"19610_CR12","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1245\/s10434-013-2988-4","volume":"20","author":"R Shridhar","year":"2013","unstructured":"Shridhar R, Hoffe SE, Almhanna K, et al. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy. Ann Surg Oncol. 2013;20:3038\u201343.","journal-title":"Ann Surg Oncol."},{"key":"19610_CR13","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1245\/s10434-012-2402-7","volume":"19","author":"YK Chao","year":"2012","unstructured":"Chao YK, Liu HP, Hsieh MJ, et al. Lymph node dissection after chemoradiation in esophageal cancer: a subgroup analysis of patients with and without pathological response. Ann Surg Oncol. 2012;19:3500\u20135.","journal-title":"Ann Surg Oncol."},{"key":"19610_CR14","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/SLA.0000000000002389","volume":"266","author":"E Visser","year":"2017","unstructured":"Visser E, van Rossum PSN, Ruurda JP, van Hillegersberg R. Impact of lymph node yield on overall survival in patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy for cancer: a population-based cohort study in the Netherlands. Ann Surg. 2017;266:863\u20139.","journal-title":"Ann Surg."},{"key":"19610_CR15","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/jso.25846","volume":"121","author":"W Lutfi","year":"2020","unstructured":"Lutfi W, Martinez-Meehan D, Dhupar R, et al. Higher lymph node harvest in patients with a pathologic complete response after neoadjuvant therapy for esophageal cancer is associated with improved survival. J Surg Oncol. 2020;121:654\u201361.","journal-title":"J Surg Oncol."},{"key":"19610_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/SLA.0000000000004798","volume":"277","author":"X Guo","year":"2023","unstructured":"Guo X, Wang Z, Yang H, et al. Impact of lymph node dissection on survival after neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: from the results of NEOCRTEC5010, a randomized multicenter study. Ann Surg. 2023;277:259\u201366.","journal-title":"Ann Surg."},{"issue":"16","key":"19610_CR17","doi-asserted-by":"publisher","first-page":"100431","DOI":"10.1016\/j.eclinm.2020.100431","volume":"25","author":"D Chen","year":"2020","unstructured":"Chen D, Mao Y, Xue Y, Sang Y, Liu D, Chen Y. Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis. EClinicalMedicine. 2020;25(16):100431.","journal-title":"EClinicalMedicine."},{"key":"19610_CR18","unstructured":"Wells GA, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed March 19, 2024."},{"key":"19610_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.7326\/0003-4819-144-6-200603210-00010","volume":"144","author":"JA Hayden","year":"2006","unstructured":"Hayden JA, C\u00f4t\u00e9 P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med. 2006;144:427\u201337.","journal-title":"Ann Intern Med."},{"key":"19610_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383\u201394.","journal-title":"J Clin Epidemiol."},{"key":"19610_CR21","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJMJ Page","year":"2021","unstructured":"Page MJMJ, Bossuyt PM. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.","journal-title":"Int J Surg."},{"key":"19610_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","volume":"358","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.","journal-title":"BMJ."},{"key":"19610_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/ejcts\/ezw246","volume":"51","author":"YK Chao","year":"2017","unstructured":"Chao YK, Chen HS, Wang BY, Hsu PK, Liu CC, Wu SC. Factors associated with survival in patients with oesophageal cancer who achieve pathological complete response after chemoradiotherapy: a nationwide population-based study. Eur J Cardiothorac Surg. 2017;51:155\u20139.","journal-title":"Eur J Cardiothorac Surg."},{"issue":"8","key":"19610_CR24","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.ejso.2019.03.020","volume":"45","author":"SL Lu","year":"2019","unstructured":"Lu SL, Hsu FM, Tsai CL, et al. Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: hypothesis generating for adjuvant treatment. Eur J Surg Oncol. 2019;45(8):1498\u2013504.","journal-title":"Eur J Surg Oncol."},{"issue":"10","key":"19610_CR25","doi-asserted-by":"publisher","first-page":"6662","DOI":"10.1245\/s10434-024-15678-y","volume":"31","author":"JY Kim","year":"2024","unstructured":"Kim JY, Yun JK, Kim YH, et al. Prognostic impact of inflammation-based factors in patients with esophageal squamous cell carcinoma achieving pathological complete response after neoadjuvant chemoradiotherapy followed by surgery. Ann Surg Oncol. 2024;31(10):6662\u201372.","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"19610_CR26","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1245\/s10434-023-14809-1","volume":"31","author":"YY Wu","year":"2024","unstructured":"Wu YY, Dai L, Yang YB, et al. Long-term survival and recurrence patterns in locally advanced esophageal squamous cell carcinoma patients with pathologic complete response after neoadjuvant chemotherapy followed by surgery. Ann Surg Oncol. 2024;31(8):5047\u201354.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"19610_CR27","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1245\/s10434-025-18599-6","volume":"33","author":"W Leijonmarck","year":"2026","unstructured":"Leijonmarck W, Mattsson F, Gottlieb-Vedi E, Wistr\u00f6m E, Kauppila JH, Lagergren J. The prognostic role of lymphadenectomy during esophagectomy for esophageal cancer with complete or near-complete tumor response after neoadjuvant therapy. Ann Surg Oncol. 2026;33(3):2065\u201373.","journal-title":"Ann Surg Oncol."},{"key":"19610_CR28","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/SLA.0000000000000965","volume":"260","author":"A Koen Talsma","year":"2014","unstructured":"Koen Talsma A, Shapiro J, Looman CW, et al. Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival. Ann Surg. 2014;260:786\u201392.","journal-title":"Ann Surg."},{"key":"19610_CR29","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.athoracsur.2013.06.050","volume":"96","author":"T Ye","year":"2013","unstructured":"Ye T, Sun Y, Zhang Y, Zhang Y, Chen H. Three-field or two-field resection for thoracic esophageal cancer: a meta-analysis. Ann Thorac Surg. 2013;96:1933\u201341.","journal-title":"Ann Thorac Surg."},{"key":"19610_CR30","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/SLA.0000000000004479","volume":"276","author":"S Sihag","year":"2022","unstructured":"Sihag S, Nobel T, Hsu M, et al. A more extensive lymphadenectomy enhances survival after neoadjuvant chemoradiotherapy in locally advanced esophageal adenocarcinoma. Ann Surg. 2022;276:312\u20137.","journal-title":"Ann Surg."},{"issue":"8","key":"19610_CR31","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.3390\/cancers16081468","volume":"16","author":"D Bona","year":"2024","unstructured":"Bona D, Manara M, Bonitta G, et al. Long-term impact of severe postoperative complications after esophagectomy for cancer: individual patient data meta-analysis. Cancers (Basel). 2024;16(8):1468.","journal-title":"Cancers (Basel)."},{"issue":"31","key":"19610_CR32","doi-asserted-by":"publisher","first-page":"51800","DOI":"10.18632\/oncotarget.15270","volume":"8","author":"SH Xie","year":"2017","unstructured":"Xie SH, Wahlin K, Lagergren J. Cause of death in patients diagnosed with esophageal cancer in Sweden: a population-based study. Oncotarget. 2017;8(31):51800\u20139.","journal-title":"Oncotarget."},{"key":"19610_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejca.2022.04.027","volume":"170","author":"JA Ajani","year":"2022","unstructured":"Ajani JA, Leung L, Singh P, et al. Disease-free survival as a surrogate endpoint for overall survival in adults with resectable esophageal or gastroesophageal junction cancer: a correlation meta-analysis. Eur J Cancer. 2022;170:119\u201330.","journal-title":"Eur J Cancer."},{"key":"19610_CR34","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Esophageal and esophagogastric junction cancers. Version 2.2023. https:\/\/www.nccn.org. Accessed March 19, 2024."},{"issue":"4","key":"19610_CR35","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/01.sla.0000184211.75970.85","volume":"242","author":"HJ Stein","year":"2005","unstructured":"Stein HJ, Feith M, Bruecher BL, Naehrig J, Sarbia M, Siewert JR. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg. 2005;242(4):566\u201373.","journal-title":"Ann Surg."},{"issue":"6","key":"19610_CR36","doi-asserted-by":"publisher","first-page":"e1022","DOI":"10.1097\/SLA.0000000000003727","volume":"274","author":"X Leng","year":"2021","unstructured":"Leng X, He W, Yang H, et al. Prognostic impact of postoperative lymph node metastases after neoadjuvant chemoradiotherapy for locally advanced squamous cell carcinoma of esophagus: from the Results of NEOCRTEC5010, a randomized multicenter study. Ann Surg. 2021;274(6):e1022\u20139.","journal-title":"Ann Surg."},{"issue":"6","key":"19610_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/jso.24050","volume":"112","author":"AU Blackham","year":"2015","unstructured":"Blackham AU, Yue B, Almhanna K, et al. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response. J Surg Oncol. 2015;112(6):597\u2013602.","journal-title":"J Surg Oncol."},{"issue":"2","key":"19610_CR38","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1245\/s10434-023-14135-6","volume":"31","author":"X Huang","year":"2024","unstructured":"Huang X, Jiang D, Jian Z, et al. Identification of optimal parameters for assessing lymph node status of patients with esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy. Ann Surg Oncol. 2024;31(2):883\u201391.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"19610_CR39","doi-asserted-by":"publisher","first-page":"e772","DOI":"10.1097\/SLA.0000000000005197","volume":"277","author":"MK Kamel","year":"2023","unstructured":"Kamel MK, Harrison S, Lee B, Port JL, Stiles BM, Altorki NK. Extended lymphadenectomy improves survival after induction chemoradiation for esophageal cancer: a propensity-matched analysis of the national cancer database. Ann Surg. 2023;277(4):e772\u20136.","journal-title":"Ann Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19610-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19610-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19610-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T04:01:32Z","timestamp":1786248092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19610-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["19610"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19610-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Not commissioned, externally peer-reviewed.","order":2,"name":"Ethics","label":"Provenance and peer review","group":{"name":"EthicsHeading","label":"Ethics"}}]}}